| 1 |
Yan J, Chen Z, Liang Y, Yang H, Cao L, Zhou Y, Zhao Y, Zhang Y. Anti-CV2/CRMP5 antibody-positive paraneoplastic neurological syndromes with chronic intestinal pseudo-obstruction in a small-cell lung cancer patient: a case report and literature review. J Int Med Res 2020;48:300060520974466. [PMID: 33305627 DOI: 10.1177/0300060520974466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Zhu CZ, Zhao HW, Lin HW, Wang F, Li YX. Latest developments in chronic intestinal pseudo-obstruction. World J Clin Cases 2020; 8(23): 5852-5865 [PMID: 33344584 DOI: 10.12998/wjcc.v8.i23.5852] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 3 |
Nham S, Nguyen ATM, Holland AJA. Paediatric intestinal pseudo-obstruction: a scoping review. Eur J Pediatr 2022. [PMID: 35482095 DOI: 10.1007/s00431-021-04365-9] [Reference Citation Analysis]
|
| 4 |
Dreyer NS, Pankratjevaite L, Janciauskas D, Saladzinskas Z. Rare case of visceral myopathy. Journal of Surgical Case Reports 2021;2021:rjab554. [DOI: 10.1093/jscr/rjab554] [Reference Citation Analysis]
|
| 5 |
Turcotte M, Faure C. Pediatric Intestinal Pseudo-Obstruction: Progress and Challenges. Front Pediatr 2022;10:837462. [DOI: 10.3389/fped.2022.837462] [Reference Citation Analysis]
|
| 6 |
Gershon MD. Hirschsprung disease and more: dysregulation of ERBB2 and ERBB3. J Clin Invest 2021;131:146389. [PMID: 33720042 DOI: 10.1172/JCI146389] [Reference Citation Analysis]
|
| 7 |
Radocchia G, Neroni B, Marazzato M, Capuzzo E, Zuccari S, Pantanella F, Zenzeri L, Evangelisti M, Vassallo F, Parisi P, Di Nardo G, Schippa S. Chronic Intestinal Pseudo-Obstruction: Is There a Connection with Gut Microbiota? Microorganisms 2021;9:2549. [PMID: 34946150 DOI: 10.3390/microorganisms9122549] [Reference Citation Analysis]
|
| 8 |
Smitka K, Prochazkova P, Roubalova R, Dvorak J, Papezova H, Hill M, Pokorny J, Kittnar O, Bilej M, Tlaskalova-Hogenova H. Current Aspects of the Role of Autoantibodies Directed Against Appetite-Regulating Hormones and the Gut Microbiome in Eating Disorders. Front Endocrinol (Lausanne) 2021;12:613983. [PMID: 33953692 DOI: 10.3389/fendo.2021.613983] [Reference Citation Analysis]
|
